ResearcherHebrew University of JerusalemNo recent work listed

Vladimir Sorin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3749-7316; OpenAlex author ID A5102739429. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2012: 1 paper

Papers 1

H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer. Co-author DOI 10.5402/2012/351750 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Abraham Czerniak · 1 shared paper, 2012 · strength 0.03
- Paper H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer. DOI 10.5402/2012/351750 ↗
Avraham Hochberg · 1 shared paper, 2012 · strength 0.03
- Paper H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer. DOI 10.5402/2012/351750 ↗
Ayala Hubert · 1 shared paper, 2012 · strength 0.03
- Paper H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer. DOI 10.5402/2012/351750 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.